Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CAMPBELL'S CoCPB · Entity 3700 | Director | September 29, 2023 | September 29, 2023 |
| COLGATE PALMOLIVE COCL · Entity 2972 | Director | October 01, 2026 | October 03, 2026 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | November 29, 2024 | December 03, 2024 |
| HERSHEY COHSY · Entity 795 | Director | April 01, 2018 | April 03, 2018 |
| TAPESTRY, INC.TPR · Entity 2309 | Director | November 14, 2024 | November 15, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CAMPBELL'S Co
Report date September 29, 2023 · Filed September 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 22,065.49 |
Reported balance
After 2023-09-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-09-29 · Grant · Acquired 1,642.03 · Balance 22,065.49 F1: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2: Phantom shares are fully vested. F3: The value of Phantom Stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4: Includes 163.60 shares acquired through dividend reinvestment since the reporting person's last report. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock.
F2: Phantom shares are fully vested.
F3: The value of Phantom Stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination.
F4: Includes 163.60 shares acquired through dividend reinvestment since the reporting person's last report.
COLGATE PALMOLIVE CO
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,725 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 271 · Balance 40,725 F1: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 4,719 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,719 |
Filing footnotes · ownership attribution and instrument terms
F1: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.
Elanco Animal Health Inc
Report date November 29, 2024 · Filed December 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 78,400 |
Reported balance
After 2024-11-29 transaction · row 1
1 source rowRow 1 · 2024-11-29 · Grant · Acquired 18,169 · Balance 78,400 F1: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. |
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 41,722 |
Reported balance
Holding disclosure · report date 2024-11-29 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 41,722 |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors.
HERSHEY CO
Report date April 01, 2018 · Filed April 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 162,148.592 |
Reported balance
After 2018-04-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-04-01 · Grant · Acquired 138.578 · Balance 162,148.592 F1: The total amount of securities reported as directly owned in Column 5 includes 9.716 shares acquired on March 15, 2018, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 342.4674 |
Reported balance
Holding disclosure · report date 2018-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 342.4674 F2: The total amount of securities reported as indirectly owned by the reporting person includes 1.7996 shares acquired from December 1, 2017 through March 5, 2018, pursuant to the Company's 401(k) Plan ("Plan"). The information is based on a report dated March 6, 2018, provided by the Plan Trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: The total amount of securities reported as directly owned in Column 5 includes 9.716 shares acquired on March 15, 2018, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders.
F2: The total amount of securities reported as indirectly owned by the reporting person includes 1.7996 shares acquired from December 1, 2017 through March 5, 2018, pursuant to the Company's 401(k) Plan ("Plan"). The information is based on a report dated March 6, 2018, provided by the Plan Trustee.
TAPESTRY, INC.
Report date November 14, 2024 · Filed November 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,846 |
Reported balance
After 2024-11-14 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2024-11-14 · Grant · Acquired 3,459 · Balance 47,846 F1: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 14, 2025. |
| Common StockSEC Table I · non-derivative | Direct | 47,846 |
Reported balance
Holding disclosure · report date 2024-11-14 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 47,846 |
Filing footnotes · ownership attribution and instrument terms
F1: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 14, 2025.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
OLAPLEX HOLDINGS, INC.
Report date July 07, 2026 · Filed July 07, 2026
Section 16 reporting ended · disclosed 2026-07-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-07-07 transaction · row 1
1 source rowRow 1 · 2026-07-07 · Disposition to issuer · Disposed 640,021 · Balance 0 F2: At the Effective Time, each award of restricted stock units covering Shares granted under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan, or any other effective equity or equity-based incentive plan sponsored by the Issuer or its affiliates (each such award, a "Company RSU Award") that was outstanding immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company RSU Award, multiplied by (y) the Merger Consideration. The amount reported includes 294,118 Shares underlying the Reporting Person's Company RSU Awards, which were automatically cancelled and converted into the right to receive the Merger Consideration at the Effective Time. F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law. |
| Common StockSEC Table I · non-derivative | IndirectBy the Amended and Restated John P. Bilbrey Revocable Declaration of Trust | 0 |
Reported balance
After 2026-07-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-07-07 · Disposition to issuer · Disposed 318,418 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law.
F2: At the Effective Time, each award of restricted stock units covering Shares granted under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan, or any other effective equity or equity-based incentive plan sponsored by the Issuer or its affiliates (each such award, a "Company RSU Award") that was outstanding immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company RSU Award, multiplied by (y) the Merger Consideration. The amount reported includes 294,118 Shares underlying the Reporting Person's Company RSU Awards, which were automatically cancelled and converted into the right to receive the Merger Consideration at the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 30, 2021 Filed May 4, 2021 00:03 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 226.0066 | $31.71 | $7,166.67 |
DisclosureSEC source: 0000950138-21-000294 · edgar.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,638.0828 Underlying: Common Stock · 226.0066 shares Expires not disclosed F1 · security: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.71 on April 30, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.71 on April 30, 2021. F1 · derivative.exercise_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 21:24 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 228 | $76.48 | $17,437.44 |
DisclosureSEC source: 0001225208-21-006474 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,375 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 22:16 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 243.3504 | $29.45 | $7,166.67 |
DisclosureSEC source: 0000950138-21-000251 · edgar.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,412.0762 Underlying: Common Stock · 243.3504 shares Expires not disclosed F1 · security: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Director' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.45 on March 31, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.45 on March 31, 2021. F1 · derivative.exercise_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Director' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Director' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 13:16 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantPhantom Stock · Derivative | 1,282.11 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-21-000042 · wf-form4_161728293571281.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,722.13 Underlying: Common Stock · 1,282.11 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 41.59 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 21:39 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 218.0971 | $32.86 | $7,166.67 |
DisclosureSEC source: 0000950138-21-000160 · edgar.xml · derivative · entry 2 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,168.7258 Underlying: Common Stock · 218.0971 shares Expires not disclosed F1 · security: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.86 on February 26, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F4 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.86 on February 26, 2021. F1 · derivative.exercise_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| January 29, 2021 Filed Mar 2, 2021 21:39 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 246.8712 | $29.03 | $7,166.67 |
DisclosureSEC source: 0000950138-21-000160 · edgar.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,950.6557 Underlying: Common Stock · 246.8712 shares Expires not disclosed F1 · security: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.03 on January 29, 2021. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.03 on January 29, 2021. F1 · derivative.exercise_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:38 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 205 | $85.10 | $17,445.50 |
DisclosureSEC source: 0001225208-21-000326 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,051 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2020 Filed Feb 16, 2021 21:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 233.6704 | $30.67 | $7,166.67 |
DisclosureSEC source: 0000950138-21-000121 · edgar.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,703.7845 Underlying: Common Stock · 233.6704 shares Expires not disclosed F1 · security: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F2 · security: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · derivative.exercise_price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $30.67 on December 31, 2020. F2 · price: The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. F3 · price: The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $30.67 on December 31, 2020. F1 · derivative.exercise_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F1 · derivative.expiration_date: Mr. Bilbrey elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. F4 · balance_after: Represents an aggregate amount of Deferred Stock Units owned by the reporting person as of fiscal year end, which includes Deferred Stock Units which were inadvertently excluded from prior filings, awarded during the years of 2019 and 2020. The number of Deferred Stock Units issued on each such award date is the amount of cash deferred divided by the closing price of a share of Elanco common stock on the award date. Read SEC document |
| December 30, 2020 Filed Jan 4, 2021 21:41 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantPhantom Stock · Derivative | 1,332.78 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-21-000020 · wf-form4_160979649554085.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,398.43 Underlying: Common Stock · 1,332.78 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 29.63 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 22:57 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 5,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000501 · edgar.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,901 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 22:20 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantStock Option · Derivative | 7,282 | $0.00 Strike: $24.71 | $0.00 |
DisclosureSEC source: 0001225208-20-013190 · doc4.xml · derivative · entry 2 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,282 Underlying: Common Stock · 7,282 shares Expires 2030-11-05 F2 · security: All of the securities acquired were issued under the Issuer's Stock Incentive Plan. Read SEC document |
| November 05, 2020 Filed Nov 6, 2020 22:20 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantCommon Stock | 3,035 | $24.71 | $74,994.85 |
DisclosureSEC source: 0001225208-20-013190 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,791 F1 · security: All of the securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on November 5, 2021. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 21:10 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 228 | $76.68 | $17,483.04 |
DisclosureSEC source: 0001225208-20-012212 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,757 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 20:41 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantPhantom Stock · Derivative | 1,332.778 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-20-000119 · wf-form4_160158488139261.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,036.022 Underlying: Common Stock · 1,332.778 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 18.90 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 00:20 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 9,580 | $26.20 | $250,996.00 |
DisclosureSEC source: 0000950138-20-000350 · edgar.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 24,222 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.15 to $26.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:34 UTC | TAPESTRY, INC. TPR · Entity 2309 | PurchaseCommon Stock | 12,980 | $15.27 | $198,204.60 |
DisclosureSEC source: 0001225208-20-010783 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,756 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.24 to $15.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 01, 2020 Filed Jul 2, 2020 20:45 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 240 | $72.82 | $17,476.80 |
DisclosureSEC source: 0001225208-20-009509 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,433 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 17:43 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantPhantom Stock · Derivative | 1,299.49 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-20-000082 · wf-form4_159371178651267.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,684.34 Underlying: Common Stock · 1,299.49 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. F4 · balance_after: Includes 9.395 shares acquired through dividend reinvestment since the reporting person's last report. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:08 UTC | TAPESTRY, INC. TPR · Entity 2309 | PurchaseCommon Stock | 7,100 | $14.12 | $100,252.00 |
DisclosureSEC source: 0001225208-20-008926 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,776 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.08 to $14.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 20:44 UTC | TAPESTRY, INC. TPR · Entity 2309 | PurchaseCommon Stock | 8,800 | $17.02 | $149,776.00 |
DisclosureSEC source: 0001225208-20-008808 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,676 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.89 to $17.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:35 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 4,155 | $0.00 Strike: $69.83 | $0.00 |
DisclosureSEC source: 0001225208-20-007608 · doc4.xml · derivative · entry 3 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,155 Underlying: Common Stock · 4,155 shares Expires 2028-05-11 F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan. F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2020 grant date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 21:35 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 2,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-007608 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,124 F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 00:22 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantStock Option · Derivative | 12,976 | $0.00 Strike: $15.38 | $0.00 |
DisclosureSEC source: 0001225208-20-006478 · doc4.xml · derivative · entry 2 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,976 Underlying: Common Stock · 12,976 shares Expires 2030-04-14 F2 · security: All of these securities acquired were issued under the Issuer's Stock Incentive Plan. Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 00:22 UTC | TAPESTRY, INC. TPR · Entity 2309 | GrantCommon Stock | 4,876 | $15.38 | $74,992.88 |
DisclosureSEC source: 0001225208-20-006478 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,876 F1 · security: All of these securities acquired were received in the form of unvested restricted stock units issued under the Issuer's Stock Incentive Plan. These securities will vest on April 14, 2021. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 21:50 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 260 | $67.31 | $17,500.60 |
DisclosureSEC source: 0001225208-20-006068 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,498 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2020 Filed Apr 1, 2020 20:24 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantPhantom Stock · Derivative | 1,375.46 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-20-000035 · wf-form4_158577264889132.xml · derivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,375.46 Underlying: Common Stock · 1,375.46 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Phantom Stock is the economic equivalent of one share of issuer common stock. F2 · derivative.exercise_date: Phantom shares are fully vested. F3 · derivative.expiration_date: The value of phantom stock is payable in cash from the Company's Supplemental Retirement Plan upon reporting person's retirement, resignation or termination. Read SEC document |
| March 06, 2020 Filed Mar 6, 2020 21:48 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 3,000 | $25.15 | $75,450.00 |
DisclosureSEC source: 0000950138-20-000140 · edgar.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 14,642 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.145 to $25.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:25 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 256 | $68.25 | $17,472.00 |
DisclosureSEC source: 0001225208-20-000552 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,162 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| November 29, 2019 Filed Dec 3, 2019 00:32 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 5,233 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000567 · edgar.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,016 F1 · price: Grant of deferred stock units as an annual equity award to each of the non-employee members of the Issuer's Board of Directors. Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 22:04 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 3,766 | $26.58 | $100,100.28 |
DisclosureSEC source: 0000950138-19-000556 · edgar.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 11,642 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.55 to $26.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F2 · balance_after: Following a review of the reporting person's stock records, it was discovered that prior filings beginning with the reporting person's Form 3 inadvertently understated the reporting person's aggregate common stock holdings by 126 shares. Column 5 now accurately reflects the number of shares of common stock held by the revocable trust of the reporting person as of November 22, 2019. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 21:55 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 241 | $72.44 | $17,458.04 |
DisclosureSEC source: 0001225208-19-013191 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,823 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 21:05 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 240 | $72.67 | $17,440.80 |
DisclosureSEC source: 0001225208-19-010057 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,507 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 07, 2019 Filed Jun 7, 2019 17:34 UTC | CAMPBELL'S Co CPB · Entity 3700 | GrantCommon Stock | 1,773 | $0.00 | $0.00 |
DisclosureSEC source: 0000016732-19-000043 · wf-form4_155992884202620.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,797 F1 · shares: Pro-rata retainer. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:35 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 4,170 | $0.00 Strike: $71.56 | $0.00 |
DisclosureSEC source: 0001225208-19-008062 · doc4.xml · derivative · entry 3 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,170 Underlying: Common Stock · 4,170 shares Expires 2027-05-13 F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan. F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2019 grant date. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:35 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 2,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-008062 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,192 F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Read SEC document |
| May 13, 2019 Filed May 15, 2019 21:43 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | PurchaseCommon Stock | 7,750 | $32.39 | $251,022.50 |
DisclosureSEC source: 0000950138-19-000302 · edgar.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Revocable Trust Disclosed balance after: 7,750 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.24 to $32.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| April 11, 2019 Filed Apr 12, 2019 21:26 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 2,783 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-19-000242 · edgar.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,783 F1 · price: Grant of deferred stock units to each of the non-employee members of the Issuer's Board of Directors, vesting three years from the date of grant. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 20:51 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 264 | $66.22 | $17,482.08 |
DisclosureSEC source: 0001225208-19-006347 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,677 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:08 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 281 | $62.24 | $17,489.44 |
DisclosureSEC source: 0001225208-19-000455 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,352 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 20:28 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 259 | $67.53 | $17,490.27 |
DisclosureSEC source: 0001225208-18-014328 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,011 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| July 02, 2018 Filed Jul 3, 2018 21:19 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 274 | $63.76 | $17,470.24 |
DisclosureSEC source: 0001225208-18-011355 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,696 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 14, 2018 Filed May 16, 2018 20:43 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantStock Option (Right to Buy) · Derivative | 6,329 | $0.00 Strike: $62.04 | $0.00 |
DisclosureSEC source: 0001225208-18-009469 · doc4.xml · derivative · entry 3 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,329 Underlying: Common Stock · 6,329 shares Expires 2024-05-14 F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan. F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 14, 2018 grant date. Read SEC document |
| May 14, 2018 Filed May 16, 2018 20:43 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 2,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-009469 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,366 F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Read SEC document |
| April 02, 2018 Filed Apr 3, 2018 20:35 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 232 | $69.83 | $16,200.56 |
DisclosureSEC source: 0001225208-18-007170 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,465 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 01, 2018 Filed Apr 3, 2018 19:19 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 138.578 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013630 · form4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,148.592 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 9.716 shares acquired on March 15, 2018, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:24 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 219 | $74.19 | $16,247.61 |
DisclosureSEC source: 0001225208-18-000303 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,923 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| January 01, 2018 Filed Jan 3, 2018 16:00 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 339.466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-000361 · form4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,000.298 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 6.731 shares acquired on December 15, 2017, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:31 UTC | COLGATE PALMOLIVE CO CL · Entity 2972 | GrantCommon Stock | 225 | $72.13 | $16,229.25 |
DisclosureSEC source: 0001225208-17-015932 · doc4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,677 F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Directors. Read SEC document |
| October 01, 2017 Filed Oct 3, 2017 12:42 UTC | HERSHEY CO HSY · Entity 795 | GrantCommon Stock | 345.941 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-028726 · form4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,654.101 F1 · ownership.direct: The total amount of securities reported as directly owned in Column 5 includes 4.870 shares acquired on September 15, 2017, pursuant to a dividend reinvestment feature of the Company's Directors' Compensation Plan, the provisions of which are substantially similar to the dividend reinvestment features of the broad-based dividend reinvestment plan available generally to Company stockholders. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 13:38 UTC | HERSHEY CO HSY · Entity 795 | Tax withholdingCommon Stock | 26,514 | $105.61 | $2,800,143.54 |
DisclosureSEC source: 0001127602-17-027547 · form4.xml · nonDerivative · entry 1 BILBREY JOHN P · CIK 0001268386 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,303.29 F1 · price: The price of the securities disposed to cover taxes associated with the distribution of previously deferred restricted stock units and performance stock units is equal to the closing price of Company's common shares on September 1, 2017, which is the date upon which the securities were released from the reporting person's account under the Company's Deferred Compensation Plan. Pursuant to the Company's payroll practices, the securities were distributed to the reporting person on September 15, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.